Priority 3 from the Mesothelioma PSP
|UNCERTAINTY: What is the best way to monitor patients with diffuse pleural thickening and a negative biopsy who are considered to have a high risk of developing mesothelioma (e.g. repeat biopsies, imaging, etc)? (JLA PSP Priority 3)
|JLA question ID
|Not available for this PSP
|No systematic reviews or studies identified
|Health Research Classification System category
|Extra information provided by this PSP
|Original uncertainty examples
|Should the clinicians perform biopsies at various time points if one biopsy result shows pleural thickening and fibrosis only?
|Outcomes to be measured
|PSP unique ID
|Total number of uncertainties identified by this PSP.
|53 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
|Date of priority setting workshop
|16 December 2014